Comorbidities in the mouse model of temporal lobe epilepsy induced by intrahippocampal kainate

Loan Samalens1,2, Camille Beets1, Clothilde Courivaud1

  • 1Grenoble Institut Neurosciences, Université Grenoble Alpes, Inserm, U1216, Grenoble, France.

Epilepsia
|July 17, 2025
PubMed
Abstract

Insights

Kainate-induced mesial temporal lobe epilepsy (MTLE) mouse models show hyperactivity and reduced well-being, similar to attention-deficit/hyperactivity disorder (ADHD) in human patients. These findings validate the model for studying MTLE comorbidities and potential treatments.

Area of Science:

  • Neuroscience
  • Epilepsy Research
  • Animal Models of Disease

Background:

  • Mesial temporal lobe epilepsy (MTLE) is frequently accompanied by cognitive and psychiatric issues.
  • The kainate-induced dorsal hippocampus model (KA-MTLE) in mice mimics key aspects of human MTLE.
  • Investigating sex-dependent comorbidities in this model is crucial for understanding MTLE.

Purpose of the Study:

  • To determine if KA-MTLE mice exhibit comorbidities similar to human MTLE patients.
  • To assess if these comorbidities are influenced by sex.
  • To validate the KA-MTLE mouse model for studying epilepsy-associated conditions.

Main Methods:

  • Male and female C57BL/6 mice received unilateral kainate injections in the dorsal hippocampus.
  • Behavioral tests evaluated food intake, well-being, impulsivity, depression, spatial and working memory, motor coordination, locomotion, and anxiety.
  • Body weight, estrous cycles, and seizure activity were monitored over two months.

Main Results:

  • KA-MTLE mice showed reduced environmental care and increased activity without anxiety or motor deficits.
  • Spatial and working memory were largely unaffected, though strategy use differed.
  • Increased body weight and longer estrous cycles in females were observed; sudden unexpected death in epilepsy (SUDEP) occurred in 10% of males and 3% of females.

Conclusions:

  • KA-MTLE mice exhibit hyperactivity and reduced well-being, mirroring attention-deficit/hyperactivity disorder (ADHD) symptoms seen in human MTLE patients.
  • The model recapitulates weight gain and SUDEP, supporting its use for studying MTLE pathophysiology.
  • This validated model aids in developing treatments for both seizures and associated comorbidities in MTLE.

Related Concept Videos